Ventas price target raised to $55 from $46 at Raymond James

Raymond James analyst Jonathan Hughes raised the firm’s price target on Ventas to $55 from $46 and keeps an Outperform rating on the shares, after raising the firm’s Healthcare REIT sector recommendation to Overweight. Ventas (VTR) remains the seniors housing relative value-play vs. Welltower (WELL), though Hughes see no identifiable catalyst to meaningfully close the gap between the two and believes both can work from here, the analyst tells investors in a research note.